1-4 of 4
Jennifer M. Knight
Close
Sort by
Journal Articles

Trends in volumes and survival after hematopoietic cell transplantation in racial/ethnic minorities

Nandita Khera, Sikander Ailawadhi, Ruta Brazauskas, Jinalben Patel, Benjamin Jacobs, Celalettin Ustun, Karen Ballen, Muhammad Bilal Abid, Miguel Angel Diaz Perez, A. Samer Al-Homsi, Hasan Hashem, Sanghee Hong, Reinhold Munker, Raquel M. Schears, Hillard M. Lazarus, Stefan Ciurea, Sherif M. Badawy, Bipin N. Savani, Baldeep Wirk, C. Fred LeMaistre, Neel S. Bhatt, Amer Beitinjaneh, Mahmoud Aljurf, Akshay Sharma, Jan Cerny, Jennifer M. Knight, Amar H. Kelkar, Jean A. Yared, Tamila Kindwall-Keller, Lena E. Winestone, Amir Steinberg, Staci D. Arnold, Sachiko Seo, Jaime M. Preussler, Nasheed M. Hossain, Warren B. Fingrut, Vaibhav Agrawal, Shahrukh Hashmi, Leslie E. Lehmann, William A. Wood, Hemalatha G. Rangarajan, Wael Saber, Theresa Hahn
Journal: Blood Advances
Blood Adv (2024) 8 (13): 3497–3506.
https://doi.org/10.1182/bloodadvances.2023012469
Published: 2024
Includes: Supplemental data
Journal Articles

Unfavorable transcriptome profiles and social disadvantage in hematopoietic cell transplantation: a CIBMTR analysis

Mallory R. Taylor, Steve W. Cole, Joelle Strom, Ruta Brazauskas, K. Scott Baker, Rachel Phelan, David Buchbinder, Betty Hamilton, Hélène Schoemans, Bronwen E. Shaw, Akshay Sharma, Neel S. Bhatt, Sherif M. Badawy, Lena E. Winestone, Jaime M. Preussler, Samantha Mayo, Kareem Jamani, Taiga Nishihori, Michelle A. Lee, Jennifer M. Knight
Journal: Blood Advances
Blood Adv (2023) 7 (22): 6830–6838.
https://doi.org/10.1182/bloodadvances.2023010746
Published: 2023
Includes: Supplemental data
Journal Articles

A timeline of genetic variant enrichment: from multiple myeloma diagnosis to myeloma-associated myeloid malignancy

Ariel Kleman, Arun Singavi, Lauren Pommert, Angela J. Mathison, Parameswaran Hari, Binod Dhakal, Meera Mohan, Siegfried Janz, Jennifer M. Knight, Mithun V. Shah, Carolina Schinke, Robert Burns, George Francis Steinhardt, Sridhar Rao, Karen Carlson
Journal: Blood Advances
Blood Adv (2023) 7 (18): 5549–5553.
https://doi.org/10.1182/bloodadvances.2022008953
Published: 2023
Includes: Supplemental data
Journal Articles

Propranolol inhibits molecular risk markers in HCT recipients: a phase 2 randomized controlled biomarker trial

Clinical Trials & Observations
Jennifer M. Knight, J. Douglas Rizzo, Parameswaran Hari, Marcelo C. Pasquini, Karen E. Giles, Anita D’Souza, Brent R. Logan, Mehdi Hamadani, Saurabh Chhabra, Binod Dhakal, Nirav Shah, Deepika Sriram, Mary M. Horowitz, Steve W. Cole
Journal: Blood Advances
Blood Adv (2020) 4 (3): 467–476.
https://doi.org/10.1182/bloodadvances.2019000765
Published: 2020
Includes: Supplemental data